SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

27 May 2024 Evaluate
The revenue for the March 2024 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -2.91 millions as compared to Net Loss of Rs. -1.48 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 improved to 1.54% as compared to -1.17% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 2.47 -0.97 -354.64 18.38 2.95 523.05 18.38 2.95 523.05
PBIDT 1.54 -1.17 -231.62 16.52 0.86 1820.93 16.52 0.86 1820.93
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 1.54 -1.17 -231.62 16.52 0.86 1820.93 16.52 0.86 1820.93
Depreciation 0.02 0.03 -33.33 0.08 0.13 -38.46 0.08 0.13 -38.46
PBT 1.52 -1.20 -226.67 16.44 0.73 2152.05 16.44 0.73 2152.05
TAX 4.43 0.28 1482.14 4.43 0.26 1603.85 4.43 0.26 1603.85
Deferred Tax 1.69 -1.04 -262.50 1.69 -1.04 -262.50 1.69 -1.04 -262.50
PAT -2.91 -1.48 96.62 12.01 0.47 2455.32 12.01 0.47 2455.32
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Starsource Multitrad Share Price

122.60 4.55 (3.85%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×